Genetic variation in human NPY expression affects stress response and emotion

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Individual differences in stress response are influenced by genetic factors affecting behavior and brain metabolism.
• Neuropeptide Y (NPY) is a key neurotransmitter with anxiolytic properties, released during stress and abundant in emotion-related brain regions.

Purpose of the Study:

• To investigate the role of NPY genetic variations (haplotypes) in predicting brain responses to emotional and stress challenges.
• To explore the correlation between NPY haplotypes, NPY expression levels, and trait anxiety.

Main Methods:

• Analysis of NPY messenger RNA (mRNA) levels in post-mortem brain tissue and lymphoblasts.
• Measurement of plasma NPY levels.
• Assessment of brain activation patterns (amygdala, opioid neurotransmission) in response to emotional and stress stimuli.
• In vitro and in vivo analysis of a specific single nucleotide polymorphism (SNP rs16147) in the NPY promoter region.

Main Results:

• NPY haplotypes accurately predicted NPY expression levels in brain and plasma.
• Lower NPY expression correlated with heightened amygdala activation to emotional stimuli.
• Reduced NPY expression was associated with diminished stress resilience, indicated by altered endogenous opioid system activation.

Conclusions:

• Haplotype-driven NPY expression is a significant predictor of individual differences in stress response and anxiety levels.
• The findings elucidate the genetic underpinnings of stress resilience and its implications for disease risk.
• A specific SNP (rs16147) in the NPY promoter region significantly influences NPY expression and may explain a substantial portion of in vivo variation.